Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Katz

Showing results (231-240 of 1,128) with videos related to

Pageof 113
Sort By:
JAMA Internal Medicine|January 14, 2020
First Physical, ReprisedRita F Redberg, Mitchell H Katz
Current HIV/AIDS Reports|August 11, 2005
Management of occupational and nonoccupational postexposure HIV prophylaxisMitchell H Katz, Julie Louise Gerberding
Journal of General Internal Medicine|December 1, 1993
Proportional hazards (Cox) regressionM H Katz, W W Hauck
Hybridoma|January 1, 1984
Mouse monoclonal IgE antibodies specific for ragweed pollen antigensF T Liu, D H Katz
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1984
FcR epsilon+ lymphocytes and regulation of the IgE antibody system. I. A new class of molecules, termed IgE-induced regulants (EIR), which modulate FcR epsilon expression by lymphocytesJ F Marcelletti, D H Katz
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1984
FcR epsilon+ lymphocytes and regulation of the IgE antibody system. IV. Delineation of target cells and mechanisms of action of SFA and EFA in inhibiting in vitro induction of FcR epsilon expressionJ F Marcelletti, D H Katz
The Journal of Experimental Medicine|October 1, 1973
The allogeneic effect in inbred mice. IV. Regulatory influences of graft-vs.-host reactions on host T lymphocyte functionsD P Osborne, D H Katz
JAMA Internal Medicine|January 13, 2021
Modernize Medical Licensing, and Credentialing, Too-Lessons From the COVID-19 PandemicDonnie L Bell, Mitchell H Katz
JAMA Internal Medicine|November 14, 2016
Statins for Primary Prevention: The Debate Is Intense, but the Data Are WeakRita F Redberg, Mitchell H Katz
JAMA|November 14, 2016
Statins for Primary Prevention: The Debate Is Intense, but the Data Are WeakRita F Redberg, Mitchell H Katz
Pageof 113

Showing results (231-240 of 1,128) with videos related to

Sort By:
Pageof 113
JAMA Internal Medicine|January 14, 2020
First Physical, ReprisedRita F Redberg, Mitchell H Katz
Current HIV/AIDS Reports|August 11, 2005
Management of occupational and nonoccupational postexposure HIV prophylaxisMitchell H Katz, Julie Louise Gerberding
Journal of General Internal Medicine|December 1, 1993
Proportional hazards (Cox) regressionM H Katz, W W Hauck
Hybridoma|January 1, 1984
Mouse monoclonal IgE antibodies specific for ragweed pollen antigensF T Liu, D H Katz
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1984
FcR epsilon+ lymphocytes and regulation of the IgE antibody system. I. A new class of molecules, termed IgE-induced regulants (EIR), which modulate FcR epsilon expression by lymphocytesJ F Marcelletti, D H Katz
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1984
FcR epsilon+ lymphocytes and regulation of the IgE antibody system. IV. Delineation of target cells and mechanisms of action of SFA and EFA in inhibiting in vitro induction of FcR epsilon expressionJ F Marcelletti, D H Katz
The Journal of Experimental Medicine|October 1, 1973
The allogeneic effect in inbred mice. IV. Regulatory influences of graft-vs.-host reactions on host T lymphocyte functionsD P Osborne, D H Katz
JAMA Internal Medicine|January 13, 2021
Modernize Medical Licensing, and Credentialing, Too-Lessons From the COVID-19 PandemicDonnie L Bell, Mitchell H Katz
JAMA Internal Medicine|November 14, 2016
Statins for Primary Prevention: The Debate Is Intense, but the Data Are WeakRita F Redberg, Mitchell H Katz
JAMA|November 14, 2016
Statins for Primary Prevention: The Debate Is Intense, but the Data Are WeakRita F Redberg, Mitchell H Katz
Pageof 113